baber/WOPTO huggingface dataset:
Patent DK-1096924-T3 (DK)
Inventor: MUNDY GREGORY R
IPC: A61K31/351
Filed: 1999-07-09
Granted: 2007-03-26
Abstract: This inventions relates to compounds that inhibit the activity of the proteasome and both promotes hair growth and stimulates the production of hair follicles. The compounds provided herein are thus useful in stimulating hair growth, including hair density, in subject where this is desirable.
Patent DK-1133366-T3 (DK)
Inventor: REISO ODDVIN
IPC: C21D1/667
Filed: 1999-11-19
Granted: 2004-02-02
Abstract: Apparatus for cooling billets (9), preferably formed of aluminum. The apparatus includes a housing (2) provided with openings (3) for axial passage of the billet through the housing, a cooling ring (4) arranged inside of the housing, and supply lines (6) for supplying a cooling medium to the housing. The cooling medium is supplied to the billet (9) in order to achieve uniform cooling, i.e. cooling without a temperature gradient, around the entire circumference of the billet. The apparatus is capable of rotating the billet while the cooling medium is supplied uniformly around the circumference of the billet (90).
Patent ES-2216751-T3 (ES)
Inventor: SCHNEIDER HUBERT
IPC: E06B3/46
Filed: 2000-03-31
Granted: 2004-11-01
Abstract: Roof window has window surface that essentially lies in plane of outer roof surface when closed and has movable window pane. window panes (1, 2) immediately adjacent to each other have common long side (3). One pane can be raised upwards and/or outwards from plane of surrounding outer roof surface (4) and other can be moved in plane of roof beneath raised pane.
Patent ES-2258972-T3 (ES)
Title: Procedimiento y terminal para entrar instrucciones.
Inventor: LAUPER ERIC
IPC: G06F3/023
Filed: 2000-05-16
Granted: 2006-09-16
Abstract: Procedimiento con el que usuarios (1) introducen instrucciones, introduciéndose dichas instrucciones con secuencias de varios movimientos voluntarios de partes del ojo, siendo introducida la secuencia individual que se necesita para la introducción de una instrucción determinada por un usuario en una fase de aprendizaje mediante varios movimientos voluntarios de partes del ojo y siendo repetida por el usuario la secuencia individualmente definida para la introducción de la instrucción determinada.
Patent ES-2272275-T3 (ES)
Inventor: CERWIN ROBERT J
IPC: B65B63/04
Filed: 2000-03-03
Granted: 2007-05-01
Abstract: A labyrinth package for sutures. The package has a base member with a top and a bottom. A labyrinth wall member extends from the top of the base member upwardly to form a labyrinth channel. The channel has an open end and a closed end. There is a vacuum opening in the bottom of the channel adjacent to the closed end. A lid is placed on top of the package. The package is loaded with sutures by using a combination of a vacuum source applied to the vacuum opening and a venturi air stream feed.
Patent ES-2225140-T3 (ES)
Inventor: GULLBERG ULF
IPC: B23Q9/00
Filed: 2000-05-04
Granted: 2005-03-16
Abstract: An auxiliary appliance, known as a mitering device, for setting the cutting angle in miter-cutting operations prior to the cutting proper, comprising two arms (1, 2), which are pivotally interconnected by means of a hinge, each one of said arms having at least one orientation face, and an angle-indicating means (4), which is connected to the arm-interconnection hinge via a gear mechanism (5), said gear mechanism being adapted, upon relative pivotal motion of the arms, to transfer essentially half of said pivotal motion to the angle-indicating means relative to the arms.
Patent ES-2296634-T3 (ES)
Title: Ensayo de diagnostico para proteina gla de matriz humana y su utilizacion como biomarcador.
Inventor: VERMEER CEES
IPC: C07K14/47
Filed: 2000-07-02
Granted: 2008-05-01
Abstract: Ensayo para la detección y determinación de proteína Gla matriz en una muestra de suero o plasma humano, comprendiendo el ensayo la utilización de uno o varios anticuerpos que reconocen específicamente epítopos en y/o conformaciones de proteína Gla matriz humana.
Patent ES-2287024-T3 (ES)
Title: Metodo y sistema de transmision de mensajes para base de datos.
Inventor: BRIQUE OLIVIER
IPC: H04N7/16
Filed: 2000-09-06
Granted: 2007-12-16
Abstract: Método de transmisión de mensajes de actualización de base de datos a partir de un centro de gestión con destino a una pluralidad de bases de datos repartidas, cada base de datos comprendiendo unos datos sistema y datos útiles, caracterizado por el hecho de que estos mensajes comprenden datos e órdenes que incluyen solicitudes sobre el contenido de una base de datos repartida, dichas órdenes efectuando unas actualizaciones condicionales de la base de datos repartida según la presencia o la ausencia de datos útiles predeterminados en el contenido de la base de datos repartida.
Patent ES-2238318-T3 (ES)
Inventor: DE NORA VITTORIO
IPC: C25C3/08
Filed: 2000-10-25
Granted: 2005-09-01
Abstract: A drained-cathode cell for the electrowinning of aluminium comprises one or more anodes (14) suspended over one or more cathodes (16). The or each anode (14) and cathode (16) respectively have a sloped V-shaped active anode surface (22) and parallel sloped inverted V-shaped drained cathode surfaces (18) facing one another and spaced apart by two sloped inter-electrode gaps (20), arranged so the electrolyte circulates upwardly in the sloped inter-electrode gaps (20) assisted by anodically produced gas and then returns from a top part (22') to a bottom part (22'') of each inter-electrode gap (20) along an electrolyte path (26,27,36,37). Each electrolyte path (26,27,36,37) extends through vertical and horizontal passages as follow: a vertical passage (27) from a top to a lower part of a cathode (16) and then a horizontal passage (26) in or under the lower part of the cathode (26), and/or a horizontal passage (36) in or on an upper part of an anode (14) and then a vertical passage (37) extending from the upper to a bottom part of the anode (14). Each horizontal passage (26,36) extends substantially over the entire horizontal length of a corresponding inter-electrode gap (20).
Patent ES-2231279-T3 (ES)
Inventor: ANKERSEN MICHAEL
IPC: C07D401/06
Filed: 2000-11-10
Granted: 2005-05-16
Abstract: The present invention describes a new compound, 2-Amino-N-[(1R)-2-[(3R)-3-benzyl-3-(N,N',N'-trimethylhydrazinocarbonyl)piperidin-1-y]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-2-methylpropionamide, having the formula:and pharmaceutically acceptable salts thereof, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone.
Patent ES-2302705-T3 (ES)
Title: Forma de dosificacion de farmaco distribuido por un hidrogel.
Inventor: APPEL LEAH ELIZABETH
IPC: A61K9/36
Filed: 2000-12-20
Granted: 2008-08-01
Abstract: Una forma de dosificación de liberación controlada que comprende un núcleo y un revestimiento alrededor de dicho núcleo, en la que: (a) dicho núcleo comprende una composición que contiene fármaco y una composición hinchable con agua, ocupando cada una regiones separadas dentro de dicho núcleo; (b) dicha composición que contiene fármaco comprende un fármaco de baja solubilidad que tiene una solubilidad acuosa mínima de hasta 1 a 2 mg/ml a pH 1-8, y un agente de arrastre de fármaco, en la que dicho agente de arrastre de fármaco es PEO que tiene un peso molecular de 500.000 a 800.000 daltons y la fracción en peso de fármaco de baja solubilidad y agente de arrastre es menos del 80% p de la composición que contiene fármaco, en la que hay una relación inversa entre el peso molecular de PEO preferido y la fracción en peso de la composición que contiene fármaco que es fármaco y agente de arrastre; en la que el peso molecular de PEO puede variar más arriba o más abajo con relación a los valores anteriores de peso molecular en el 20% al 50%; y (c) dicho revestimiento es permeable al agua, insoluble en agua y tiene al menos una abertura de suministro a su través; y en la que dicha composición que contiene fármaco comprende además un polímero aumentador de la concentración seleccionado entre acetato succinato de hidroxipropilmetilcelulosa (HPMCAS), ftalato de hidroxipropilmetilcelulosa (HPMCP), acetato ftalato de celulosa (CAP) y acetato trimelitato de celulosa (CAT); y dicho fármaco no está en forma de dispersión sólida.
Patent ES-2206354-T3 (ES)
Inventor: DEROUAULT PHILIPPE
IPC: B29C49/12
Filed: 2000-12-26
Granted: 2004-05-16
Abstract: A blow molding machine including at least a blow mold (12), wherein is introduced a preform (14) previously produced by injection molding, and a blow nozzle (22) for injecting pressurized air into the preform (14). It is equipped with a device for orienting the preform in the mold, the device including a grip member (30) adapted to grip the preform (14) by its neck (18) when it is engaged in the mold (12); a device (66) for driving in rotation the grip member (30); a device for detecting (70) at least a reference angular position of the preform (14); and a control device to cause the grip member to rotate until the detecting device detects the reference angular position of the preform.
Patent ES-2211737-T3 (ES)
Inventor: MARCO LESLIE S
IPC: B65D71/08
Filed: 2001-06-28
Granted: 2004-07-16
Abstract: A container carrier (10) unitizes a plurality of containers (50) into a package (15) having sleeve (30) with a retainer portion (33) formed with a plurality of container receiving openings (20) arranged in three longitudinal rows. A plurality of containers (50) are arranged within the sleeve (30) in two levels. The retainer portion preferably includes a handle (35) for supporting the package (15). A tear strip (45) in the sleeve is used to separate the upper and lower levels of containers (50) into separable part packs. The handle (35), sleeve (30) and retainer portion (33) are integrated together to form a single piece carrier (10). <IMAGE>
Patent ES-2267704-T3 (ES)
Inventor: ZILIANI MASSIMO
IPC: B21D39/04
Filed: 2001-07-24
Granted: 2007-03-16
Abstract: The present invention concerns a radial press made up of: a lower fixed block (10) resting on a platform (11); a top block (13) placed above and facing the lower block (10) and movable vertically in relation to the latter for opening/closing the press; a cylinder (24) for rapid approach/retract of the top block (13) towards/away from the block (10), and drive units (23) for reciprocal compression of said blocks (10,13), where said lower and top blocks form between them a number of right-angled surfaces (14,15) used to support and guide the clamps (18) of the press where the top block is guided towards the lower block by a pair of columns (21). Said drive units are made up of a cylinder (23) in which a drive piston (25) is housed and to which both guide columns are anchored (21). <IMAGE>
Patent ES-2286108-T3 (ES)
Inventor: VON KNEBEL DOEBERITZ MAGNUS
IPC: C12N5/09
Filed: 2001-02-07
Granted: 2007-12-01
Abstract: A pharmaceutical preparation, comprising a cell-cycle regulatory protein, and/or a nucleic acid encoding that protein, for immunization against carcinoma and its preliminary stages, is new. - ACTIVITY : Cytostatic. Peripheral blood lymphocytes were isolated from an HLA-A0201 positive sample by density centrifugation and T lymphocytes were separated from monocytes and B lymphocytes using antibodies coupled to magnetic beads (CD11, CD16, CD19, CD36 and CD56) (T cell isolation kit, Milteny, Germany). Peptides of p16 were identified using a software system (NIH bioinformation service) including the following peptides ValMetMetMetGlySerAlaArgVal, ValLeuHisArgAlaGlyAlaArgLeu, TheLeuThrArgProValHisAspAla, LeuLeuHisGlyAlaGluProAsnCys, SerMetGluProSerAlaAspMetLeu, MetMetGlySerAlaArgValAlaGluLeu, LeuLeuLeuHisGlyAlaGluProAsnCys, GlyValMetMetMetGlySerAlaArgVal. The isolated T cells were incubated with T2 cells and a mixture of the 9mer (a) or 10mer (b) peptides. The T cells were re-stimulated weekly over a six week period. In each case 10 7> T-cells were co-cultivated with 2x10 6> peptide-loaded T2 cells in 24 well plates. Reaction against the peptide-loaded T2 cells was determined weekly using an interferon (IFN)-lambda enzyme linked immunosorbent assay (ELISA). On day 28 reaction against mixture (a) was observed with the main reaction being against peptide ValMetMetMetGlySerAlaArgVal (1000 specific cells per million cells), and a weaker reaction against mixture (b) with peptide MetMetGlySerAlaArgValAlaGluLeu being the highest (600 specific cells per million cells). Thus it is clear that CD8 +> T-cells can be stimulated against p16. These activated T-cells were incubated with human leukocyte antigen (HLA) A0201+ Caski cervix carcinoma cells which over-express p16, and with colon carcinoma line SW480 which do not over-express p16. The Caski cells were lysed, whilst the controls were not. - MECHANISM OF ACTION : Vaccine; gene therapy.
Patent ES-2250374-T3 (ES)
Inventor: IMAMURA KOJI
IPC: A61K8/00
Filed: 2001-04-05
Granted: 2006-04-16
Abstract: The present invention provides a minoxidil-containing composition which can be prevented from coloring for a long period of time. The composition, which comprises an anti-oxidant such as dibutylhydroxytoluene, butylhydroxyanisole or erythorbic acid, and has a pH of from 5.5 to 7.0.
Patent ES-2351957-T3 (ES)
Inventor: IMGRUND MICHAEL
IPC: A61K33/00
Filed: 2001-01-31
Granted: 2011-02-14
Abstract: The present invention relates to a method for treating, delaying and/or preventing renal dysfunction/failure in a mammal comprising administering a therapeutically effective amount of a substance capable of inducing and/or enhancing Pax2 expression. Furthermore, the invention relates to the use of an effective dose of a substance capable of inducing and/or enhancing Pax2 expression in a mammal for the preparation of a pharmaceutical composition for treating, preventing or delaying a renal dysfunction/failure in a mammal. Additionally, the present invention provides for a method for converting mesenchymal tissue into an epithelial tissue comprising the administration of an effective amount of a substance capable of inducing and/or enhancing Pax2 expression in said mesenchym and for a method for the regeneration of renal stemcells comprising the administration of an effective amount of a substance capable of inducing and/or enhancing Pax2 expression.
Patent ES-2249426-T3 (ES)
Title: Dispositivo de suspension de chasis en aluminio para sistemas de eje/sispension.
Inventor: RAMSEY JOHN E
IPC: B62D21/00
Filed: 2001-03-21
Granted: 2006-04-01
Abstract: Conjunto de chasis de vehículo que incluye un dispositivo de suspensión de chasis de aluminio (24A, B) que suspende un conjunto de suspensión de un sistema de eje/suspensión (15A, B) desde el chasis de un vehículo de aluminio (10¿), incluyendo dicho chasis un par de elementos principales separados transversalmente que se extienden longitudinalmente (11¿) y una pluralidad de travesaños (12A¿, 12B¿) que se extienden entre dichos elementos principales y que los conectan entre sí, incluyendo dicho sistema de eje/suspensión (15A, B) un par de conjuntos de suspensión separados transversalmente, incluyendo cada uno de dicho par de conjuntos de suspensión una viga (32¿) que se extiende longitudinalmente, capturando dichas vigas del citado par de conjuntos de suspensión un eje que se extiende transversalmente y presentando por lo menos una rueda montada en cada extremo de dicho eje, incluyendo cada una de dichas vigas en un extremo un conjunto de casquillo (35¿) para el montaje de manera giratoria de la viga (32¿) en dicho dispositivo de suspensión del chasis.
Patent ES-2313958-T3 (ES)
Inventor: CONSTANTZ BRENT R
IPC: C04B24/00
Filed: 2001-04-27
Granted: 2009-03-16
Abstract: Methods are provide for producing flowable compositions, e.g. pastes, that set into calcium phosphate products. In the subject methods, dry reactants that include a calcium source and a phosphate source are combined with a solution of a soluble silicate, e.g. sodium silicate, and the combined liquids and solids are mixed to produce the flowable composition. Also provided are the compositions themselves as well as kits for preparing the same. The subject methods and compositions produced thereby find use in a variety of applications, including the repair of hard tissue defects, e.g. bone defects.
Patent ES-2230342-T3 (ES)
Title: Herramienta de elevacion integrada para la instalacion de un ascensor.
Inventor: GLASSEY TOM E
IPC: B66B19/00
Filed: 2001-07-06
Granted: 2005-05-01
Abstract: Conjunto de ascensor, que comprende: una viga de máquina (32) que se extiende a través de un hueco de ascensor; un conjunto de máquina (19) que incluye un motor de elevación para elevar una cabina (24) de ascensor y un bastidor para montar dicho motor de elevación (20), estando soportado dicho conjunto de máquina por dicha viga de la máquina; caracterizado porque comprende, además, un cable (30) por el cual se suspende dicho conjunto de máquina durante el montaje; y una herramienta de elevación (35) que incluye un motor para accionar dicho cable para elevar dicho conjunto de máquina hacia arriba a través de dicho hueco de ascensor (23) hasta una localización de viga sobre dicha viga de máquina, estando fijada dicha herramienta de elevación a dicha viga de la máquina.
Patent ES-2282291-T3 (ES)
Inventor: SINGEISEN FELIX
IPC: H04L29/06
Filed: 2001-10-10
Granted: 2007-10-16
Abstract: The invention relates to a method and a device for checking, optionally monitoring, a network supporting WAP terminals (WAP-MS) working according to the Wireless Application Protocol (WAP) and having a WAP gateway (WAP-GW) which connects a mobile radio telephone network (PLMN) and a network that works according to Internet protocols TCP/IP, Internet or Intranet, and which adapts the protocols (WAP, HTTP) of transmitted messages (REQUEST/RESPONSE). According to the invention, the data flow progression of at least one or more processes running parallel for the transmission of data between a WAP terminal (MS) and a Web server (WEB-SRV) are recorded in the WAP terminal (MS), at the WAP-side and the Internet-side input of the WAP gateway (WAP-GW) and optionally in the Web server (WEB-SRV) and then transmitted to a management system (MMS) that is designed to process the measured data, said data being then processed therein. The method disclosed in the invention makes it possible to promptly determine the state or changes in the checked network and localize the causes of detected changes.
Patent ES-2231555-T3 (ES)
Title: Soporte anti-vibratorio para un medio de conexion de sujecion con abrazadera y vehiculo equipado con este soporte.
Inventor: MELLON PAUL
IPC: F16F1/38
Filed: 2001-09-06
Granted: 2005-05-16
Abstract: Soporte anti-vibratorio que consta de unas estructuras rígidas primera (1) y segunda (2), que se pueden unir respectivamente a dos elementos rígidos (1a, 2a) que se han de conectar, un cuerpo de elastomero (3) que conecta las dos estructuras entre si y esta diseñado para soportar una carga axial permanente a lo largo de un primer eje (Z), el cuerpo de elastomero esta unido a un manguito (10) instalado en una barra de montaje (5) que pertenece a la primera estructura (1) y se extiende a lo largo de un segundo eje (X) sustancialmente perpendicular al primer eje (Z), en el cual el manguito (10) se retiene sobre la barra de montaje (5) por una conexión de enganche rápido (15, 19).
Patent ES-2302778-T3 (ES)
Inventor: ENDERS BERNHARD
IPC: C11D3/12
Filed: 2002-11-02
Granted: 2008-08-01
Abstract: Use is claimed in bleach-free detergents of water-soluble builders which have a particle size distribution such that particles of sizes from 0.2 to below 0.4 mm are excluded.
Patent ES-2298323-T3 (ES)
Inventor: KELLER MANFRED
IPC: A61K38/095
Filed: 1999-11-10
Granted: 2008-05-16
Abstract: The use of magnesium stearate (I) in dry powder formulations for inhalation to improve resistance to moisture is new. Independent claims are also included for: (1) the use of magnesium stearate to reduce the effect of invasive moisture on the fine particles in dry powders for inhalation; and (2) dry powder formulations for inhalation comprising: (a) an inactive carrier of non-inhalant particle size; (b) a pharmaceutically active agent in the form of a salt or ester of inhalant particle size; and (c) 0.25-1 wt.% of magnesium stearate.
Patent ES-2222429-T3 (ES)
Inventor: NICCOLAI FABRIZIO
IPC: A61M15/00
Filed: 2002-12-03
Granted: 2005-02-01
Abstract: A device defining a chamber (17) for housing a capsule (18) containing a product in fine powder form, comprising a manually movable part (11,12,13) provided with rods (15) which perforate the capsule when the movable part (11,12,13) is operated and leave the capsule (18) when the movable part (11,12,13) is released, the entire product in powder form escaping from the capsule (18) to be inhaled. <IMAGE>
Patent ES-2241950-T3 (ES)
Title: Sistema de inyeccion hipodermico sin aguja, dispositivo de aplicacion y cartucho de farmaco para el mismo.
Inventor: IHLE GUENTER FRANZ
IPC: A61M5/24
Filed: 2002-03-05
Granted: 2005-11-01
Abstract: Dispositivo de aplicación para la inyección hipodérmica sin aguja de un medicamento líquido (16), de manera que dicho dispositivo de aplicación(41) comprende a) una carcasa (42, 44) que tiene un eje longitudinal y una superficie de contacto exterior(91) que se ha adaptado para poderse aplicar a una superficie cutánea a través de la cual se aplica una inyección, b) dicha carcasa (42, 44) que contiene un medio de inyección (35, 62) que provoca la eyección de dicho medicamento líquido (16) para realizar una inyección, y un medio de accionamiento (63) para activar dicho medio de eyección (35, 62), caracterizada por que el dispositivo de aplicación (41) comprende además c) un medio de detección de la posición (92, 93, 94, 96, 97, 98, 99, 72, 103) para detectar si dicha superficie de contacto(91) de dicha carcasa (42, 44) ejerce una presión predeterminada en dicha superficie cutánea y si al mismo tiempo dicho eje longitudinal de dicha carcasa (42, 44) está colocado básicamente normal a dicha superficie cutánea (91), siendo la distribución de dicha presión sobre el área de dicha superficie de contacto(91) sustancialmente uniforme, de forma que dicho medio para detectar (92, 93, 94, 96, 97, 98, 99, 72, 103) capacite a dicho medio de accionamiento(63) cuando se cumplen las condiciones mencionadas.
Patent ES-2359390-T3 (ES)
Title: Composición de tinción para fibras queratínicas que contiene una silicona aminada particular.
Inventor: LEGRAND FREDERIC
IPC: A61K8/38
Filed: 2002-11-04
Granted: 2011-05-23
Abstract: Composición de tinción para fibras queratínicas humanas, que contiene, en un medio cosméticamente aceptable, al menos un colorante directo o al menos un colorante de oxidación, caracterizada por contener además al menos una silicona aminada de las fórmulas (I) o (II) siguientes: fórmula (I) en la cual: m y n son números tales que la suma (n + m) varía de 1 a 1.000, designando n un número de 0 a 999 y designando m un número de 1 a 1.000; R1, R2 y R3, idénticos o diferentes, representan un radical hidroxi o alcoxi C1-C4, designando uno al menos de los radicales R1 a R3 un radical alcoxi; fórmula (II) en la cual: p y q son números tales que la suma (p + q) varía de 1 a 1.000, designando p un número de 0 a 999 y designando q un número de 1 a 1.000; R1 y R2, diferentes, representan un radical hidroxi o alcoxi C1-C4, designando uno al menos de los radicales R1 a R2 un radical alcoxi.
Patent ES-2230462-T3 (ES)
Inventor: BIANCHI CARLO
IPC: A43D25/18
Filed: 2002-06-20
Granted: 2005-05-01
Abstract: Method for applying a glue to an insole for shoes by using a machine for manufacturing shoes, comprising the following steps: positioning on a support element a shoe form on which an upper is stretched and to whose underside an insole for shoes is associated, the latter extending between a back end and a front end, supplying a glue on a portion of the insole through one or more glue suppliers (22) which can move on said portion of the insole so as to follow a predetermined path and be pressingly engaged with the insole, to keep the insole itself in contact with the underside of the form. At the end of the step of supplying the glue at least a glue supplier disengages from the insole by a disengagement point placed near the front end of the insole. <IMAGE>